Fundz

Accutar Biotechnology Inc. reported raising $28 Million in an initial SEC Form D filing, from an offering of $28 Million

PRIVATEAug 01, 2019

Amount Raised

$28 Million

$28 Million sold, per SEC Form D (first sale Aug 1, 2019)

Round Type

Venture

New YorkBiotechnology

Quick answer

Accutar Biotechnology Inc. raised $28 Million in a funding round, dated August 1, 2019. Accutar Biotechnology Inc. is based in New York, New York, United States.

How much did Accutar Biotechnology Inc. raise?
Accutar Biotechnology Inc. raised $28 Million in a funding round on August 1, 2019.
Where is Accutar Biotechnology Inc. based and how big is it?
Accutar Biotechnology Inc. is based in New York, New York, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Accutar Biotechnology Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Alto Neuroscience raised $7.7M on September 13, 2019.
  • PROGENITY, INC. raised $25M on September 13, 2019.
  • Brava Diagnostics, Inc. raised $250K on September 13, 2019.
  • Arrevus, Inc. raised $150K (Seed) on September 13, 2019.
  • Cidara Therapeutics raised $9M on September 13, 2019.
  • SeLux Diagnostics, Inc. raised $9M on September 12, 2019.

Who to call at Accutar Biotechnology Inc., and when

A new round usually means Accutar Biotechnology Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Accutar Biotechnology Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Accutar Biotechnology Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Accutar Biotechnology Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Accutar Biotechnology Inc.

Location

235 E 55TH ST. APT. 42A

New York, New York, United States

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Accutar Biotechnology Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Accutar Biotechnology Inc.'s next move

See what Strategic adds

Accutar Biotechnology Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.